Neurophysiological Study of Sativex in Multiple Sclerosis (MS) Spasticity
Clinical trial NCT01538225 · COMPLETED
Trial details
- NCT number
- NCT01538225
- Sponsor
- Almirall, S.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-11-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.